BENDAMUSTINE HYDROCHLORIDE

Generic: BENDAMUSTINE HYDROCHLORIDE

Apotex CorpManufacturer
INTRAVENOUSRoute
BENDAMUSTINE HYDROCHLORIDEActive Substance
2022-12-07Original Approval

BENDAMUSTINE HYDROCHLORIDE is FDA application NDA215033, sponsored by APOTEX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
995 reports
2
PYREXIA
555 reports
3
DISEASE PROGRESSION
510 reports
4
COVID-19
406 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
400 reports
6
DRUG INEFFECTIVE
392 reports
7
FEBRILE NEUTROPENIA
366 reports
8
MALIGNANT NEOPLASM PROGRESSION
362 reports
9
NEUTROPHIL COUNT DECREASED
354 reports
10
NEUTROPENIA
344 reports